Publication | Closed Access

Estimation of the Absolute Bioavailability of Rivastigmine in Patients with Mild to Moderate Dementia of the Alzheimer???s Type

Neurodegenerative DiseasesAlzheimer's DiseaseGeriatricsMedicineDementiaAbsolute BioavailabilityS TypeVascular Cognitive DisorderVascular DementiaFrontotemporal DementiaNeurologyAging-associated DiseaseModerate DementiaPharmacology